These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The spectrum of statin myopathy. Mohassel P; Mammen AL Curr Opin Rheumatol; 2013 Nov; 25(6):747-52. PubMed ID: 24061077 [TBL] [Abstract][Full Text] [Related]
7. Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study. Musset L; Allenbach Y; Benveniste O; Boyer O; Bossuyt X; Bentow C; Phillips J; Mammen A; Van Damme P; Westhovens R; Ghirardello A; Doria A; Choi MY; Fritzler MJ; Schmeling H; Muro Y; García-De La Torre I; Ortiz-Villalvazo MA; Bizzaro N; Infantino M; Imbastaro T; Peng Q; Wang G; Vencovský J; Klein M; Krystufkova O; Franceschini F; Fredi M; Hue S; Belmondo T; Danko K; Mahler M Autoimmun Rev; 2016 Oct; 15(10):983-93. PubMed ID: 27491568 [TBL] [Abstract][Full Text] [Related]
8. Immune-Mediated Necrotizing Myopathy: Update on Diagnosis and Management. Basharat P; Christopher-Stine L Curr Rheumatol Rep; 2015 Dec; 17(12):72. PubMed ID: 26515574 [TBL] [Abstract][Full Text] [Related]
9. Spectrum of immune-mediated necrotizing myopathies and their treatments. Pinal-Fernandez I; Mammen AL Curr Opin Rheumatol; 2016 Nov; 28(6):619-24. PubMed ID: 27607340 [TBL] [Abstract][Full Text] [Related]
10. Atorvastatin-induced necrotizing autoimmune myositis: An emerging dominant entity in patients with autoimmune myositis presenting with a pure polymyositis phenotype. Troyanov Y; Landon-Cardinal O; Fritzler MJ; Ferreira J; Targoff IN; Rich E; Goulet M; Goulet JR; Bourré-Tessier J; Robitaille Y; Drouin J; Albert A; Senécal JL Medicine (Baltimore); 2017 Jan; 96(3):e5694. PubMed ID: 28099331 [TBL] [Abstract][Full Text] [Related]
11. Autoimmune necrotising myopathy and HMGCR antibodies. Karunaratne K; Amiras D; Pickering MC; Hofer M; Viegas S Pract Neurol; 2018 Apr; 18(2):151-155. PubMed ID: 29439058 [TBL] [Abstract][Full Text] [Related]
12. [Dermatomyositis-like syndrome revealing statin-induced necrotizing autoimmune myopathy with anti-HMGCR antibodies]. Merlant M; Fite C; Kottler D; Maisonobe L; Dossier A; Deschamps L; Descamps V Ann Dermatol Venereol; 2019 Sep; 146(8-9):550-556. PubMed ID: 30929872 [TBL] [Abstract][Full Text] [Related]
13. Statins and myositis: the role of anti-HMGCR antibodies. Selva-O'Callaghan A; Alvarado-Cardenas M; Marin A; Pinal-Fernandez I Expert Rev Clin Immunol; 2015; 11(12):1277-9. PubMed ID: 26492593 [TBL] [Abstract][Full Text] [Related]
14. Use of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Statin-Associated Immune-Mediated Necrotizing Myopathy: A Case Series. Tiniakou E; Rivera E; Mammen AL; Christopher-Stine L Arthritis Rheumatol; 2019 Oct; 71(10):1723-1726. PubMed ID: 31058470 [TBL] [Abstract][Full Text] [Related]
15. Mushroom supplements triggering a flare of HMGCR immune mediated necrotising myopathy. Adler B; Christopher-Stine L; Tiniakou E BMJ Case Rep; 2022 May; 15(5):. PubMed ID: 35606030 [TBL] [Abstract][Full Text] [Related]
16. Statin-naïve anti-HMGCR antibody-mediated necrotizing myopathy in China. Jiao Y; Cai S; Lin J; Zhu W; Xi J; Li J; Yue D; Zhang T; Qiao K; Wang Y; Zhao C; Lu J J Clin Neurosci; 2018 Nov; 57():13-19. PubMed ID: 30205933 [TBL] [Abstract][Full Text] [Related]